MCMCB Pro
S0077

S0077Injection, clindamycin phosphate, 300 mg

HCPCSTerminatedBETOS Z2

S0077 is a HCPCS Level II code for injection, clindamycin phosphate, 300 mg. It belongs to the Temporary National Codes (Non-Medicare) section. It was terminated on June 30, 2023 and is not valid on new claims.

This code has been terminated

CMS terminated S0077 on June 30, 2023. It stays in the file as history — a claim you are auditing from before that date may legitimately carry it — but it must not appear on a new claim. The adjacent codes below are the usual place to look for its replacement.

Medicare coverage: Not payable by Medicare

Medicare does not pay this code. It may still be valid for another payer, but a Medicare claim carrying it will not be reimbursed.

From the coverage field of the CMS Alpha-Numeric HCPCS File, release 2026Q3-Jul. This states Medicare’s position on the code, not on your particular claim.

The CMS record for S0077

Long descriptor
Injection, clindamycin phosphate, 300 mg

The official wording. This is what the code means.

Short descriptor
Injection, clindamycin phosp

CMS's 28-character form, which is what shows up on a remittance advice.

Added
January 1, 2000

When CMS introduced the code.

Terminated
June 30, 2023

When CMS retired it.

BETOS
Z2

Berenson-Eggers Type of Service — CMS's own analytic grouping.

Pricing indicator
00 — Not priced by Part B

Service not separately priced by Part B — not covered, bundled into another service, or used by Part A only.

Codes adjacent to S0077

HCPCS has no hierarchy — related items simply sit next to each other in the numbering. If S0077 is not quite right, the correct code is very often within a few positions of it.

  • S0028Injection, famotidine, 20 mgterminated
  • S0030Injection, metronidazole, 500 mgterminated
  • S0032Injection, nafcillin sodium, 2 gramsterminated
  • S0034Injection, ofloxacin, 400 mg
  • S0039Injection, sulfamethoxazole and trimethoprim, 10 mlterminated
  • S0040Injection, ticarcillin disodium and clavulanate potassium, 3.1 grams
  • S0073Injection, aztreonam, 500 mgterminated
  • S0074Injection, cefotetan disodium, 500 mgterminated
  • S0078Injection, fosphenytoin sodium, 750 mg
  • S0080Injection, pentamidine isethionate, 300 mgterminated
  • S0081Injection, piperacillin sodium, 500 mg
  • S0088Imatinib, 100 mg
  • S0090Sildenafil citrate, 25 mg
  • S0091Granisetron hydrochloride, 1 mg (for circumstances falling under the medicare statute, use q0166)
  • S0092Injection, hydromorphone hydrochloride, 250 mg (loading dose for infusion pump)
  • S0093Injection, morphine sulfate, 500 mg (loading dose for infusion pump)

Questions about S0077

What is HCPCS code S0077?

S0077 is a HCPCS Level II code for injection, clindamycin phosphate, 300 mg. It sits in the Temporary National Codes (Non-Medicare) section.

Does Medicare cover S0077?

The CMS HCPCS file marks S0077 as "Not payable by Medicare". Medicare does not pay this code. It may still be valid for another payer, but a Medicare claim carrying it will not be reimbursed.

Is S0077 still valid?

No. S0077 was terminated on June 30, 2023 and should not be used on new claims.

HCPCS Level II2026Q3-Jul· effective July 1, 2026